Dr. Kathryn Martin Remington is a Technical Consultant in the Technical and Scientific Solutions group at MilliporeSigma and provides U.S. clients with technical and regulatory support. Kathy joined the organization in 2010 from Catalent Pharma Solutions where she established a viral clearance program. She was also the section head of the Viral Validation group for Bayer Healthcare. During over 25 years in viral clearance, she has authored a number of publications on the viral safety of biopharmaceuticals. Kathy earned her M.S. and Ph.D. degrees in Microbiology from the University of Montana.